« Return to News | Miscellaneous

CWWeekly February 18th 2008 Issue

Friday, February 22, 2008 11:47 AM

Top News

 

ICON Acquires Phase I Unit in Texas

Dublin, Ireland-based ICON made its move into the U.S. phase I market with its acquisition of Healthcare Discoveries, a San Antonio, Texas-based 40,000-square-foot, 85-bed clinical pharmacology unit. The company, owned by Catalyst Pharma Group, was purchased by ICON for $12 million in cash and performance payments of up to $10 million to be paid by the end of 2008. The buy will more than double ICON’s total phase I capability and expand its services across the Atlantic. ICON already operates an 80-bed, full-service pharmacology unit in Manchester, England.

Chiltern Buys Second Phase I Unit in UK

London-based contract research organization (CRO) Chiltern acquired Drug Development Solutions (DDS), a phase I facility based in Dundee, Scotland. The 45-bed unit is located at the Hospital and Medical School. Including the company’s facility in Slough, Chiltern now has a total of 72 beds in its phase I division.

Other breaking news...      

  • KCR acquires Dux Consulting...
  • Quintiles central laboratory in India receives CAP certification...

Company Profile: An interview with Vijai Kumar, M.D., president and chief medical officer, Excel Life Sciences

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.